Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,149.00    10.00 (0.88%)
Bid:
1,148.50
Ask:
1,149.50
Spread: 1.00 (0.087%)
Market Cap: £9.75b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Total Voting Rights

1 Jun 2020 11:53

RNS Number : 5497O
Smith & Nephew Plc
01 June 2020
 

1 June 2020

 

Voting Rights and Capital

 

 

 

In conformity with Rule 5.6 of the FCA's Disclosure and Transparency Rules:-

 

The total issued share capital of Smith & Nephew plc (the "Company") as at 31 May 2020 comprises 884,748,666 ordinary shares of US20¢ each ("ordinary shares"), including 9,199,123 ordinary shares held in treasury.

 

The Company's issued share capital, with one voting right per share, therefore consists of 875,549,543 ordinary shares. This is the figure, which should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0) 1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRKZGGVGMMGGZM
Date   Source Headline
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20255:08 pmRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20254:30 pmRNSHolding(s) in Company
7th Aug 20253:15 pmRNSHolding(s) in Company
7th Aug 202510:34 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:01 amRNSShare Buyback Programme
5th Aug 20257:00 amRNSHalf-year Report
1st Aug 202510:21 amRNSTotal Voting Rights
21st Jul 202511:51 amRNSNotice of Results
11th Jul 202510:00 amRNSDirector/PDMR Shareholding
1st Jul 20251:30 pmRNSTotal Voting Rights
13th Jun 20257:00 amRNSDirectorate Change
6th Jun 20254:16 pmRNSDirector/PDMR Shareholding
2nd Jun 20252:07 pmRNSTotal Voting Rights
30th May 20251:22 pmRNSDirector/PDMR Shareholding
21st May 20253:00 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSSterling Amount of Dividend
7th May 202511:53 amRNSDirector/PDMR Shareholding
2nd May 202511:30 amRNSDirector/PDMR Shareholding
1st May 202511:27 amRNSTotal Voting Rights
30th Apr 20255:30 pmRNSResult of AGM
30th Apr 20257:00 amRNSSmith+Nephew First Quarter 2025 Trading Update
28th Apr 20251:49 pmRNSHolding(s) in Company
25th Apr 20259:18 amRNSDirectorate Change
22nd Apr 20257:00 amRNSNotice of Results
1st Apr 202512:41 pmRNSTotal Voting Rights
27th Mar 20259:17 amRNSDirector/PDMR Shareholding
27th Mar 20259:12 amRNSDirector/PDMR Shareholding
11th Mar 20253:25 pmRNSDirector/PDMR Shareholding
10th Mar 20252:46 pmRNSAnnual Financial Report
3rd Mar 20252:58 pmRNSTotal Voting Rights
25th Feb 20257:00 amRNSFinal Results
12th Feb 20257:11 amRNSBlock listing Interim Review
6th Feb 20257:00 amRNSNotice of Results
3rd Feb 202510:27 amRNSTotal Voting Rights
14th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202512:51 pmRNSTotal Voting Rights
20th Dec 20249:46 amRNSDirector/PDMR Shareholding
16th Dec 202411:50 amRNSHolding(s) in Company
12th Dec 20249:53 amRNSHolding(s) in Company
11th Dec 20249:03 amRNSHolding(s) in Company
9th Dec 20243:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.